Barrington Research Maintains Outperform on Concentrix, Lowers Price Target to $30
Barrington Research analyst Vincent Colicchio maintains Concentrix (NASDAQ: CNXC ) with a Outperform and lowers the price target from $38 to $30.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.